Clinical Trials Browser

INDUSTRY × Lymphoma, Non-Hodgkin × ADI PEG20 × Clear all

NCT01910025 2018-09-18

PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy

Phase 2 Completed

Lymphoma, Non-Hodgkin